Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
Astor's Q3 showed a clear recovery from the weaker second quarter. Stronger deliveries, improved cost absorption and a pickup in order intake provide a firmer base for further growth, despite uneven progress across the portfolio. Order intake regained...
Astor's growth potential remains attractive, although order timing warrants a more cautious earnings outlook. We cut estimates and our PT to reflect sustained order intake weakness and delivery risks, while retaining BUY. Q3 should bring sequential margin...
Astor's Q2 showed its new scale following the NSG acquisition, while delivery phasing and mix weighed on underlying margins ahead of a backlog-supported H2.